GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Square Pharmaceuticals PLC (DHA:SQURPHARMA) » Definitions » E10

Square Pharmaceuticals (DHA:SQURPHARMA) E10 : BDT19.48 (As of Dec. 2024)


View and export this data going back to . Start your Free Trial

What is Square Pharmaceuticals E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Square Pharmaceuticals's adjusted earnings per share data for the three months ended in Dec. 2024 was BDT7.450. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is BDT19.48 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Square Pharmaceuticals's average E10 Growth Rate was 13.80% per year. During the past 3 years, the average E10 Growth Rate was 17.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Square Pharmaceuticals was 17.20% per year. The lowest was -4.20% per year. And the median was 6.50% per year.

As of today (2025-03-14), Square Pharmaceuticals's current stock price is BDT219.90. Square Pharmaceuticals's E10 for the quarter that ended in Dec. 2024 was BDT19.48. Square Pharmaceuticals's Shiller PE Ratio of today is 11.29.

During the past 13 years, the highest Shiller PE Ratio of Square Pharmaceuticals was 22.15. The lowest was 8.95. And the median was 13.38.


Square Pharmaceuticals E10 Historical Data

The historical data trend for Square Pharmaceuticals's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Square Pharmaceuticals E10 Chart

Square Pharmaceuticals Annual Data
Trend Mar15 Mar16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.36 11.40 14.13 16.13 18.34

Square Pharmaceuticals Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.12 17.89 18.34 18.93 19.48

Competitive Comparison of Square Pharmaceuticals's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Square Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Square Pharmaceuticals's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Square Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Square Pharmaceuticals's Shiller PE Ratio falls into.



Square Pharmaceuticals E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Square Pharmaceuticals's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=7.45/133.1571*133.1571
=7.450

Current CPI (Dec. 2024) = 133.1571.

Square Pharmaceuticals Quarterly Data

per share eps CPI Adj_EPS
201503 1.989 99.621 2.659
201506 2.051 100.684 2.713
201509 2.237 100.392 2.967
201512 2.385 99.792 3.182
201603 0.000 100.470 0.000
201606 0.000 101.688 0.000
201609 2.732 101.861 3.571
201612 2.770 101.863 3.621
201703 3.311 102.862 4.286
201706 3.188 103.349 4.107
201709 3.394 104.136 4.340
201712 3.222 104.011 4.125
201803 3.356 105.290 4.244
201806 3.106 106.317 3.890
201809 3.578 106.507 4.473
201812 3.524 105.998 4.427
201903 3.514 107.251 4.363
201906 3.646 108.070 4.492
201909 3.781 108.329 4.648
201912 3.980 108.420 4.888
202003 4.080 108.902 4.989
202006 3.210 108.767 3.930
202009 4.440 109.815 5.384
202012 4.330 109.897 5.246
202103 4.360 111.754 5.195
202106 4.869 114.631 5.656
202109 5.640 115.734 6.489
202112 5.240 117.630 5.932
202203 5.150 121.301 5.653
202206 4.450 125.017 4.740
202209 6.200 125.227 6.593
202212 5.780 125.222 6.146
202303 4.830 127.348 5.050
202306 4.590 128.729 4.748
202309 6.770 129.860 6.942
202312 5.920 129.419 6.091
202403 5.550 131.776 5.608
202406 5.367 132.554 5.391
202409 6.870 133.029 6.877
202412 7.450 133.157 7.450

Add all the adjusted EPS together and divide 10 will get our e10.


Square Pharmaceuticals  (DHA:SQURPHARMA) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Square Pharmaceuticals's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=219.90/19.48
=11.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Square Pharmaceuticals was 22.15. The lowest was 8.95. And the median was 13.38.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Square Pharmaceuticals E10 Related Terms

Thank you for viewing the detailed overview of Square Pharmaceuticals's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Square Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
Square Centre, 48, Mohakhali Commercial Area, Dhaka, BGD, 1212
Square Pharmaceuticals PLC is a Bangladesh-based pharmaceutical company engaged in the manufacturing and marketing of generic pharmaceuticals products, Basic chemical products, and animal health products. The company operates in one segment, which is the business of developing, manufacturing, and marketing drugs for health care for all living species. It manufactures drugs like paracetamol, clotrimazole, antiallergic, Nitroglycerin, xylometazoline HCl, erythromycin, and various other drugs. Company also provides devices such as AnsuPen and AnsuPen Twist. The company operates in Bangladesh and sells its products locally and internationally.

Square Pharmaceuticals Headlines

No Headlines